Resultados de la búsqueda 581-590 of 2230 for GLP-1 agonists
Patients will receive VSL#3® 450B sachets probiotics, which will be provided as part of this trial, at least 3 days but preferably 1-2 weeks prior to starting ...
Colorectal cancer is the third most commonly diagnosed cancer in both men and women in the United States (1). Colorectal cancer arises from colonic polyps. The ...
Rochester, Minn. This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with ...
Patients will be randomized 1:1 into the two arms. ... Patients will be randomized in a 1:1 ... Avelumab In Combination Regimens That Include An Immune Agonist ...
The purpose of this study is to measure and characterize specific immune cell abnormalities found in patients who have type 1 diabetes and may or may not be on ...
Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri, Dec 05, 2025. See more discussions. Relacionado. Displasia fibromuscular ...
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...
Eligible patients presenting with apparent uterine confined grade 1, 2, or 3 endometrioid endometrial cancer will undergo standard-of-care primary surgical ...
Study participation is up to 6 months (24 weeks of treatment) followed by surgery and a one-month follow up visit. A Study of a New Molecular Approach to ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?